Industry News
Pharmaceutical Industry News
After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli
After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli fkansteiner Thu, 12/09/2021 - 09:42
Square pumping $74M into Kenya plant as Africa draws more manufacturing interest
Square pumping $74M into Kenya plant as Africa draws more manufacturing interest jkeenan Thu, 12/09/2021 - 08:58
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problems
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people preexposure
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure kdunleavy Wed, 12/08/2021 - 17:40
AstraZeneca’s Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposure
AstraZeneca's Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposure kdunleavy Wed, 12/08/2021 - 17:40
Klick Health spreads good cheer, and $100 bills, in annual holiday video highlighting the joy of giving
Klick Health spreads good cheer, and $100 bills, in annual holiday video highlighting the joy of giving nmissakian Wed, 12/08/2021 - 17:30
As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the case
As end of New York opioid trial nears, AbbVie's Allergan ponies up $200M to settle its part of the case fkansteiner Wed, 12/08/2021 - 14:22
ASH: Servier’s Tibsovo triumph in leukemia study primes med for combo use—and possibly Europe
ASH: Servier's Tibsovo triumph in leukemia study primes med for combo use—and possibly Europe fkansteiner Wed, 12/08/2021 - 13:08
ASH: Bristol Myers’ Breyanzi, Gilead’s Yescarta lock horns in race to move CAR-T therapy to earlier lymphoma
ASH: Bristol Myers' Breyanzi, Gilead's Yescarta lock horns in race to move CAR-T therapy to earlier lymphoma aliu Wed, 12/08/2021 - 12:29
Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protection
Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protection kdunleavy Wed, 12/08/2021 - 11:16
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicron
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets case
Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets case fkansteiner Wed, 12/08/2021 - 10:34
Teligent, Edge Pharma yank meds on superpotency, sterility concerns
Teligent, Edge Pharma yank meds on superpotency, sterility concerns fkansteiner Wed, 12/08/2021 - 09:05
J&J celebrates nurses with a new campaign in wake of burnout plaguing the profession
J&J celebrates nurses with a new campaign in wake of burnout plaguing the profession sharon.coey Wed, 12/08/2021 - 04:10
Elizabeth Holmes Returns to the Stand on Tuesday.
The climax of the cross-examination of Ms. Holmes, founder of the blood testing start-up Theranos, sends her fraud trial to its end stage.
Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trial
Shkreli's former company Vyera settles for $40M in antitrust case, but 'pharma bro' still faces his own trial fkansteiner Tue, 12/07/2021 - 16:35
Merck KGaA launches new digital ‘lifeline’ to help patients finance fertility treatment
Merck KGaA launches new digital 'lifeline' to help patients finance fertility treatment nmissakian Tue, 12/07/2021 - 16:16
Call for nominations: The Most Influential People in Biopharma
Call for nominations: The Most Influential People in Biopharma esagonowsky Tue, 12/07/2021 - 14:22
Former pharma CEO plundered millions from his own company, DOJ says
Former pharma CEO plundered millions from his own company, DOJ says fkansteiner Tue, 12/07/2021 - 11:16
Watch out, Pfizer and Alnylam. AstraZeneca wades deeper into rare diseases with Ionis tie-up
Watch out, Pfizer and Alnylam. AstraZeneca wades deeper into rare diseases with Ionis tie-up aliu Tue, 12/07/2021 - 10:42